[Studies of dialysis patients using the 14C aminophenazone breath test].
In 12 endstage kidney disease patients (8 liver healthy and 4 with liver diseases) the activities of cytochrome P450-dependentmixed functional oxidases system (MFO) of the liver were studied by using the 14C-aminophenazon breath test before and after dialysis. We were interested in the influence of uremia and dialysis treatment on MFO-activity. Our results show that uremia seems to have a pressing influence on MFO-activity. The activity was only significantly increased after dialysis in the group of patients without liver disease. We observed that the MFO-activity was reduced in patients with liver diseases. This is a restriction of the liver metabolic demethylation capacity. It is unclear if the 14C-aminophenazone breath test in dialysis patients is qualified to estimate metabolic capacity of the liver. Differentiation between the influence of uremia and of the liver disease on the alteration of MFO-activity cannot be made.
Heinrich
H G
HG
Klinik für Innere Medizin, Medizinischen Akademie, Carl Gustav Carus, Dresden, DDR.
Mayer
W K
WK
Adler
D
D
Hornak
H
H
Wünschmann
H J
HJ
D000632:Aminopyrine; D001944:Breath Tests / Q000379:methods*; D002250:Carbon Radioisotopes; D006521:Hepatitis, Chronic / Q000201:enzymology*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000201:enzymology*; D008099:Liver / Q000201:enzymology; D008103:Liver Cirrhosis / Q000201:enzymology*; D008111:Liver Function Tests; D006899:Mixed Function Oxygenases / Q000097:blood*; D006435:Renal Dialysis
D002250:Carbon Radioisotopes; D000632:Aminopyrine; D006899:Mixed Function Oxygenases
Untersuchungen von Dialysepatienten mit dem 14C-Aminophenazon-Atemtest.